Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683–693
PubMed
Article
CAS
Google Scholar
Varagnolo L, Stokkel MPM, Mazzi U, Pauwels EK (2000) 18F-Labeled radiopharmaceuticals for PET in oncology, excluding FDG. J Nuc Med Biol 27:103–112
Article
CAS
Google Scholar
Gunneriussoin E, Nord K, Uhlen M, Nygren P (1999) Affinity maturation of a Taq DNA polymerase specific Affibody by helix shuffling. Protein Eng 12:873–878
Article
Google Scholar
Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M, Nygren P-A (1997) Binding protein selected from combinatorial libraries on an alpha-helical bacterial receptor domain. Nat Biotechnol 15:772–777
PubMed
Article
CAS
Google Scholar
Tran T, Engfeld T, Orlova A et al (2007) In vivo evaluation of cystine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules. Bioconjugate Chem 18:549–558
Article
CAS
Google Scholar
Orlaova A, Magnusson M, Eriksson TL et al (2006) Tumor imaging using a picomolar affinity HER2 binding Affibody molecule. Cancer Res 66:4339–4348
Article
Google Scholar
Orlova A, Tolmachev V, Pehrson R et al (2007) Synthetic Affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors. Cancer Res 67:21788–2186
Article
Google Scholar
Poethko T, Schottelius M, Thumshirn G et al (2004) Two-step methodology for high yield routine radiohalogenation of peptides: 18F-labeled RGD and octreotide analogs. J Nucl Med 45:892–902
PubMed
CAS
Google Scholar
Toyokuni T, Walsh JC, Dominguez A, Phelps ME, Barrio JR, Gambhir SS, Satyamurthy N (2003) Synthesis of a new hetrobifunctional linker, N-[4-(aminooxy)butyl]maleimide, for facile access to a thiol-reactive 18F-labeling agent. Bioconjug Chem 14:1253–1259
PubMed
Article
CAS
Google Scholar
Berndt M, Pietzsch J, Wuest F (2007) Labeling of low-density lipoproteins 18F-labeled thiol-reactive reagent N-[6-[18F]fluorobenzylidine)aminooxyhexyl]maeimide. Nucl Med Biol 34:5–25
PubMed
Article
CAS
Google Scholar
Cai W, Zhang X, Wu Y, Chen X (2006) A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptides-based tracer for PET imaging of αvβ3 integrine expression. J Nucl Med 47:172–180
Google Scholar
Calzadilla M, Cordovoa T, Malpica A (1990) Effect of structure on reactivity in oxime formation of benzaldehyde. J Phys Org Chem 12:408–712
Google Scholar
Rosenbeg S, Silver SM, Sayer JM, Jacks WP (1974) Evidence for two concurrent mechanisms and a kinetically significant proton transfer in avid-catalyzed O-methyloxime formation. J Am Chem Soc 96:798
Google Scholar
Hang HC, Bertozzi CR (2001) Chemoselective approaches to glycoprotein assembly. Acc Chem Res 34:727–736
PubMed
Article
CAS
Google Scholar
Cornish VW, Hahn KM, Schultz PG (1996) Site-specific protein modification using a ketone handle. J Am Chem Soc 118:8150–8151
Article
CAS
Google Scholar
Gilmore JM, Scheck RA, Esser-Kahn AP, Joshi NA, Francis MB (2006) N-terminal protein modification through a biomimetic transamination reaction. Angew Chem Int Ed 45:5307–5311
Article
CAS
Google Scholar
Ruiz-Chica AJ, Medina MA, Sanchez-Jimenez F, Ramirez FJ (2004) On the interpretation of Raman spectra of 1-aminooxy-spermine/DNA complex. Nucleic Acids Res 32:579–589
PubMed
Article
CAS
Google Scholar
Yu D, Wolf JK, Scanlon M et al (1993) Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Research 53:891–898
PubMed
CAS
Google Scholar
Engfeldt T, Tran T, Orlova A et al (2007) (99m)Tc-chelator engineering to improve tumor targeting properties of a HER2-specific Affibody molecule. Eur J Nucl Med Mol Imaging 34:1843–1853
PubMed
Article
CAS
Google Scholar